Background: Despite the fact that thrice-weekly hemodialysis is regarded as the standard for maintenance dialysis, prescription of twice-weekly hemodialysis with a longer treatment time is common in Hong Kong to allow more renal failure patients to receive treatment. In an attempt to assess whether clinical and biochemical parameters differ between hemodialysis with different interdialytic intervals, we investigated the urea kinetics and blood biochemistry parameters in patients undergoing two dialysis sessions per week. Methods: Data were collected for 16 anuric stable maintenance dialysis patients for two dialyses in the same week. Results: Compared with hemodialysis after a short interdialytic interval (HD SII ), hemodialysis after a long interdialytic interval (HD LII ) led to significantly greater interdialytic weight gain. Predialysis plasma potassium, urea and creatinine concentrations were significantly higher for HD LII . On the other hand, there were no significant differences in predialysis plasma sodium, chloride, total carbon dioxide, albumin, calcium and phosphorus concentrations and anion gap between HD SII and HD LII . Both immediate postdialysis and 30-minute postdialysis plasma urea concentrations were significantly higher for HD LII . Urea removal, creatinine removal, modified urea reduction ratio (mURR), single-pool Kt/V (spKt/V) and equilibrated Kt/V (eKt/V) were significantly greater for HD LII . Moreover, there was a good linear relationship between mURR for HD SII and HD LII . Similar findings were noted for both spKt/V and eKt/V. However, there were no differences between the two dialyses in urea reduction ratio, normalized protein equivalent of total nitrogen appearance and postdialysis urea rebound. Conclusion: Our findings suggest that there are differences in some dialysis indices and blood biochemistry parameters between HD SII and HD LII . Standardization of dialysis sessions (HD SII or HD LII ) for blood sampling schedules is needed to permit meaningful comparison of dialysis indices and biochemistry parameters within and between dialysis patients. [Hong Kong J Nephrol 2004;6(1):43-51] 
INTRODUCTION
Following analysis of the National Cooperative Dialysis Study, it is agreed that prescription of an adequate hemodialysis dose is important to improve clinical outcome [1] . It is recommended that standard maintenance hemodialysis should take place three times per week [2, 3] , and that the treatment time should be 4 hours per session [3] . A reduction in dialysis frequency to twice per week is considered inappropriate unless there is significant residual renal function [2, 3] . Thus, it is not surprising that the use of twice-weekly hemodialysis in the USA has decreased from 12.9% to 3.6% for incident hemodialysis patients (defined as those with a diagnosis of end-stage renal disease and treated with hemodialysis for less than 12 months [4] ) between 1990 and 1996 [5] . Similarly, in Australia and New Zealand, only 1% to 2% of patients are treated using two hemodialysis sessions per week [6] . However, twice-weekly hemodialysis is still common in some countries. In the UK, for instance, twice-weekly hemodialysis is used in more than 5% of patients in 38% of surveyed renal units, and in more than 20% of patients in 5% of units [7] . In Iran, 42.5% of hemodialysis patients receive dialysis twice weekly [8] . Similarly, because of limited availability of hemodialysis facilities in Hong Kong, it is common to prescribe twice-weekly hemodialysis to allow more patients to be treated. In our centers, more than 80% of chronic hemodialysis patients are prescribed a twice-weekly regimen. However, a longer treatment time (4-5.5 hours) than in the thrice-weekly regimen is usually prescribed to compensate for the lost day of treatment [3] .
Dialysis units may quantify the hemodialysis dose and measure the clinical chemistry parameters either at the beginning-of-the-week or the end-of-the-week dialysis session for patients on twice-weekly hemodialysis. However, it should be noted that these clinical parameters may be affected by the length of interdialytic interval. Moreover, either session could be the hemodialysis after a short interdialytic interval (HD SII ) or that after a long interdialytic interval (HD LII ). For instance, Monday could be the HD LII for a Monday/ Thursday schedule, while it is the HD SII for a Monday/ Friday schedule. If there are significant differences in dialysis indices and clinical chemistry parameters between the HD SII and HD LII , it will be necessary to standardize blood sampling schedules to permit meaningful comparisons of data for a single patient over time, among patients and among different hemodialysis facilities. Therefore, we undertook the present study to W= !"#$ea pff = =ea iff = !"#$%&'()*+,-./ 01&!234%& !"#$%&'(") *ea pff = =ea iff !"#$%&'()*+,-./01 234 !"#$%&'()*$+,-./()*$01234,-56789:;<6-= investigate whether there were any differences in urea kinetics and blood biochemistry parameters for the two dialyses in patients on twice-weekly hemodialysis. Patients were dialyzed as usual, maintaining their types of dialyzer, dialysate, dialyzer blood flow rate, dialysate flow rate, treatment time, dry weight and dialysis shift (morning or afternoon) during the entire study. Two dialysis treatments in the same week (HD SII and HD LII ) were studied. Blood samples drawn before dialysis from the dry arterial tubing after insertion of the needle into the vascular access were used for sodium, potassium, urea, creatinine, total carbon dioxide, chloride, albumin, calcium and phosphorus analysis. Two postdialysis blood samples were taken from the arterial bloodline sampling port for urea analysis, one at 15 seconds postdialysis when the blood pump rate had slowed to 50 mL/min for 15 seconds, and the other 30 minutes after stopping dialysis. A partial dialysate collection method was used to procure a representative sample of the total spent dialysate [9, 10] . All dialysate urea concentrations were analyzed in duplicate.
PATIENTS AND METHODS

Urea kinetics and biochemistry in patients on twice-weekly HD
Single-pool Kt/V (spKt/V), equilibrated Kt/V (eKt/V), urea reduction ratio (URR), modified urea reduction ratio (mURR), normalized protein equivalent of total nitrogen appearance (nPNA), and postdialysis urea rebound were calculated [11] [12] [13] [14] (equations described in Appendix A). Results are expressed as median and interquartile range. Wilcoxon's signed-rank test was used to compare clinical and biochemical parameters for HD SII and HD LII . Correlation between the dialysis indices of HD SII and HD LII were analyzed using Pearson's correlation coefficient. A p value of less than 0.05 was considered statistically significant.
RESULTS
No adverse events were reported during the study. In particular, there was no intradialytic episode of hypotension or any event that required interruption or early termination of dialysis treatment. Table 1 shows the clinical parameters for the two dialyses. As expected, the dialysis-free interval before the HD LII was significantly longer than that before the HD SII . Interdialytic weight gain was significantly great-er for HD LII than for HD SII , but this significance disappeared after adjusting for interdialytic interval. Predialysis plasma potassium, urea and creatinine concentrations were significantly higher for HD LII than for HD SII (Table 2 ). There were no differences in predialysis plasma sodium, chloride, total carbon dioxide, albumin, calcium and phosphorus concentrations or anion gap between HD SII and HD LII . The immediate and 30-minute postdialysis plasma urea concentrations for HD LII were significantly greater than those for HD SII . Despite significantly higher predialysis, immediate postdialysis and 30-minute postdialysis plasma urea concentrations for HD LII , there were no differences in the ratios of immediate postdialysis to predialysis plasma or 30-minute postdialysis to predialysis plasma urea concentrations between the two dialyses ( Table 3) . As there was no change in dialysis prescription, including dry weight, it was not surprising that the volume of ultrafiltrate was significantly greater for HD LII to tackle the higher interdialytic weight gain (Tables 1 and 3) . Table 4 shows the dialysis indices for the two dialyses. The amount of urea and creatinine removed per dialysis and the mURR, spKt/V and eKt/V for HD LII Data are expressed as median (interquartile range). HD SII = hemodialysis after a short interdialytic interval (3-day interval); HD LII = hemodialysis after a long interdialytic interval (4-day interval). Data are expressed as median (interquartile range). HD SII = hemodialysis after a short interdialytic interval (3-day interval); HD LII = hemodialysis after a long interdialytic interval (4-day interval); CO 2 = carbon dioxide. Data are expressed as median (interquartile range). HD SII = hemodialysis after a short interdialytic interval (3-day interval); HD LII = hemodialysis after a long interdialytic interval (4-day interval); URR = urea reduction ratio; mURR = modified urea reduction ratio; spKt/V = single-pool Kt/V; eKt/V = equilibrated Kt/V; nPNA = normalized protein equivalent of total nitrogen appearance. Data are expressed as median (interquartile range). HD SII = hemodialysis after a short interdialytic interval (3-day interval); HD LII = hemodialysis after a long interdialytic interval (4-day interval); R = immediate postdialysis plasma urea to predialysis plasma urea ratio; R' = 30-minute postdialysis plasma urea to predialysis plasma urea ratio.
were significantly greater than those for HD SII . There was a strong linear correlation for mURR between the two dialyses ( Figure 1) . Similarly, there was a strong linear correlation between the two dialyses for Kt/V levels (both spKt/V and eKt/V) (Figures 2 and 3 ). However, there were no differences in URR and nPNA dialysis. There was a significantly greater interdialytic weight gain for HD LII than for HD SII , but the difference was no longer significant after adjusting for interdialytic interval. This suggests that patients might not adjust their dietary fluid intake in the long interdialytic interval. There were also significantly higher predialysis concentrations of plasma potassium, urea and creatinine for HD LII . The differences in predialysis blood biochemistry appear to be related to the longer interdialytic interval and effect of dietary intake. Another factor that might influence predialysis blood biochemistry is the time of day of the dialysis. Predialysis plasma potassium concentrations increased progressively for patients dialyzed later in the day compared with earlier dialysis shifts [15] . However, this factor might not be relevant because all patients kept their dialysis shifts unchanged during the study. There were significant differences in some but not all dialysis indices between HD SII and HD LII . These discrepancies could be explained by the way the indices are derived. The absolute values of pre-and postdialysis plasma urea concentrations are not required in the calculation of URR, which is estimated by the ratio of post-to predialysis plasma urea [12] . Our results show that, despite higher pre-and postdialysis plasma urea concentrations for HD LII , there was no difference in the ratio of post-to predialysis plasma urea between the two dialyses. Hence, it is not surprising that there was no difference in URR between HD SII and HD LII . In contrast to URR, mURR and Kt/V consider the effects of ultrafiltration and intradialytic urea generation [11, 13] . Apart from the ratio of post-to predialysis plasma urea, estimations of mURR and Kt/V (both spKt/V and eKt/V) require input of dialysis session length, ultrafiltrate volume and postdialysis body weight. The higher mURR and Kt/V values for HD LII were primarily a reflection of the greater ultrafiltrate volume for HD LII , which is the only parameter that was significantly different between the two dialyses ( Table 3 ). Based on our findings, the difference in Kt/V values between the two dialyses will be exaggerated for patients with a small post-to predialysis plasma urea ratio and for patients with big differences in ultrafiltrate volume between the dialyses (Appendix B).
It is well known that hemodialysis treatment time affects solute removal and, hence, blood biochemistry. Moreover, a difference in the treatment time without a change in dialysis frequency unavoidably affects the interdialytic interval. For instance, a longer treatment time will be associated with a shorter dialysis-free interval. Thus, it is possible that the treatment time might also have an effect on urea kinetics and biochemistry parameters. Our data suggest that the treatment time might affect the relationship of clinical parameters between HD SII and HD LII , but the discrepancy between the findings in the two groups levels between HD SII and HD LII . No difference was noted in the postdialysis urea rebound between the two dialyses.
To evaluate the effect of dialysis treatment time on urea kinetics and clinical chemistry, the data were further categorized according to treatment time (Table  5 ). Within each group, clinical parameters were compared for HD SII and HD LII . In both groups, the predialysis plasma urea and creatinine and 30-minute postdialysis plasma urea concentrations were significantly greater for HD LII compared with HD SII . In contrast to patients dialyzed for the longer treatment time, patients treated for the short time demonstrated no significant differences in interdialytic weight gain, predialysis plasma potassium, volume of ultrafiltrate, urea removal, creatinine removal, mURR, spKt/V and eKt/V between HD SII and HD LII . Among patients treated for the longer time, there was no significant difference in the immediate postdialysis plasma urea concentration between HD SII and HD LII .
DISCUSSION
These results suggest that there are significant differences in certain clinical parameters, blood biochemistry parameters and dialysis indices between HD SII and HD LII for patients on twice-weekly hemo- Data are expressed as median. HD SII = hemodialysis after a short interdialytic interval (3-day interval); HD LII = hemodialysis after a long interdialytic interval (4-day interval); CO 2 = carbon dioxide; R = immediate postdialysis plasma urea to predialysis plasma urea ratio; R' = 30-minute postdialysis plasma urea to predialysis plasma urea ratio; URR = urea reduction ratio; mURR = modified urea reduction ratio; spKt/V = single-pool Kt/V; eKt/V = equilibrated Kt/V; nPNA = normalized protein equivalent of total nitrogen appearance. *The small numbers may prevent detection of statistically significant differences because of a lack of power. † p < 0.05, HD SII vs HD LII .
could also be related to the small sample size of the subgroup analysis. Further study is needed to reevaluate this. Our findings have several potential implications for the care of patients on twice-weekly hemodialysis. Patients on hemodialysis are prone to develop fluid overload and hyperkalemia because of kidney failure. Our data showed that there were mean differences of 0.81 kg in interdialytic weight gain and of 0.33 mmol/L in predialysis plasma potassium between HD SII and HD LII . These differences may be clinically significant for patients who are on the verge of developing fluid overload or hyperkalemia. Patients should be advised to pay extra attention to dietary compliance, especially in the long interdialytic interval. The dialysis schedule for patients on twice-weekly hemodialysis could be Monday/Thursday, Monday/Friday, Tuesday/Friday, Tuesday/Saturday or Wednesday/Saturday. If increasing dialysis frequency is deemed impossible or unfeasible, it is not advisable to put patients with a history of recurrent heart failure or hyperkalemia on a Monday/Thursday schedule in dialysis centers where service is not available on Sunday because these patients are prone to develop fluid overload and hyperkalemia on Sunday (i.e. the day before the scheduled HD LII on Monday).
For patients on thrice-weekly hemodialysis, it is recommended that the dialysis dose be estimated at the midweek dialysis session [2, 3] . However, there is no established consensus on which dialysis session should be used to measure dialysis dose for patients on twiceweekly hemodialysis. Our results substantiate the need to standardize the blood-sampling schedule because there were significant differences in some dialysis indices between the two dialyses. Although the differences might be small (mean differences of 1.3% in mURR, 0.08 in spKt/V values, and 0.06 in eKt/V levels between the two dialyses), standardization of dialysis session for hemodialysis dose quantification is necessary to allow reliable and valid comparison of adequacy of dialysis parameters within and between end-stage renal disease patients and clinical trials. Equations describing the mathematical relationship in mURR, spKt/V and eKt/V between HD LII and HD SII were derived by linear regression analysis (Figures 1-3 ). These simple equations may be useful in qualityassurance programs or in epidemiologic studies to adjust for the effect of interdialytic interval on dialysis indices when only limited data concerning dialysis treatment are available. Finally, the present study was not designed to assess which dialysis session should be used to quantify the dialysis dose. However, in view of the fact that a higher predialysis plasma potassium concentration was found for HD LII , we suggest that the routine blood sampling for quantification of dialysis dose and predialysis blood biochemistry monitoring be standardized on HD LII . This arrangement may help to identify patients who are at risk of developing hyperkalemia so that early intervention can be given.
The present study has some limitations. First, the sample size is small, which may prevent the detection of statistically significant differences in some clinical parameters because of a lack of power. Second, the patients recruited were anuric and extrapolation of the results to patients with significant urine output should be undertaken with caution. Residual renal function could affect blood biochemistry, interdialytic weight gain and, hence, ultrafiltrate volume.
In conclusion, our data suggest that there may be differences in some clinical parameters, blood biochemistry parameters and dialysis indices between HD SII and HD LII for patients on twice-weekly hemodialysis. The findings may help in the design of dialysis and bloodsampling schedules to identify patients who are at risk of developing hyperkalemia. They also substantiate the need to standardize the schedule for dialysis dose estimation to allow meaningful comparison of dialysis indices within and between end-stage renal disease patients. BW Postdialysis body weight, kg c Creatinine concentration in the spent dialysate, mmol/L C 1 Predialysis plasma urea, mmol/L C 2 Postdialysis plasma urea, obtained at the end of dialysis after having slowed down the blood pump rate to 50 mL/min for 15 seconds, mmol/L C 3 Equilibrated postdialysis plasma urea, obtained 30 minutes after termination of hemodialysis, mmol/L Creat Creatinine removed by dialysis, mmol Qd Dialysate flow rate, L/hr R C 2 /C 1 R' 
Appendix A
Meaning of symbols
Calculation of URR [12]
URR = (1 -R) 100%
Calculation of mURR [13]
mURR = {1 -[R/(1 + 2UF/BW)] + 0.01t] 100%
Calculations of Kt/V [11]
spKt/V = -ln(R -0.008t) + (4 -3.5R) UF/BW eKt/V = -ln(R' -0.008t) + (4 -3.5R') UF/BW Calculation of nPNA [14] nPNA (HD SII ) = {C 1 
